Catalent - Asia-Pacific clinical packaging facilities

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

FDA approves Takeda's ALUNBRIG ® (brigatinib) as a first-line treatment for patients with rare and severe forms of lung cancer

Monday, May 25, 2020

Takeda Pharmaceutical Company Limited TSE NYSE TAK announced today that the US Food and Drug Administration FDA is approved for ALUNBRIG Brigatinib for adult patients with anaplastic lymphoma kinase ALK positive metastatic nonsmall cell lung cancer...

AbCellera Announces Multi-Year Antibody Discovery Collaboration with Lilly

Saturday, May 23, 2020

AbCellera announced that it has entered into a multiyear strategic research collaboration and license agreement with Eli Lilly and Company Lilly on the discovery of antibodies for up to nine Lillyselected therapeutic targets Lilly will have the right...

Kleo Pharmaceuticals and Celularity Enter into Research Collaboration

Friday, May 22, 2020

Kleo Pharmaceuticals Inc a leading company in the field of developing nextgeneration fully synthetic bispecific compounds designed to emulate or enhance the activity of biologics and Celularity Inc a leading developer of allogeneic or offtheshelf nat...

GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio

Friday, May 22, 2020

GlaxoSmithKline plc and Samsung Biologics KS have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSKs innovative biopharmaceutical therapies

Rentschler Biopharma Licenses Horizon Discovery’s CHOSOURCE Platform to Complement Cell Line Development Offering for Difficult-To-Express Proteins

Thursday, May 21, 2020

Rentschler Biopharma SE a worldclass contract development and manufacturing organization CDMO for biopharmaceuticals and Horizon Discovery a global leader in the application of gene editing and gene modulation for cell line engineering today announce...

Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart

Thursday, May 21, 2020

Kindred Biosciences Inc a biopharmaceutical company developing novel biologics announced it has entered into an agreement with Vaxart Inc Nasdaq VXRT for the manufacture of Vaxarts oral vaccine candidate for COVID

Amplyx Pharmaceuticals Advances Development of Novel Antifungal, Fosmanogepix

Wednesday, May 20, 2020

Amplyx Pharmaceuticals a biotech company developing innovative therapies for debilitating and lifethreatening diseases in patients with compromised immune systems announced today that it has advanced development of its lead program fosmanogepix APX E...

PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology

Wednesday, May 20, 2020

PharmaJet the maker of innovative needlefree injection technology today announced that its Needlefree Injection System technology will be used to deliver a messenger RNA mRNA vaccine against SARSCoV The vaccine is being developed by Abnova Corporatio...

Innovent Biologics and MD Anderson Announce a Strategic Collaboration to Develop anti-PD-1 Therapy TYVYT® (Sintilimab Injection) in Rare Cancers

Tuesday, May 19, 2020

Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of cancer autoimmune metabolic and other major diseases and The University of Texas MD Anderson Cancer...

ENHERTU® Granted Breakthrough Therapy Designation in the U.S. for HER2 Mutant Metastatic Non-Small Cell Lung Cancer

Monday, May 18, 2020

Daiichi Sankyo Company Limited and AstraZenecas ENHERTU has been granted Breakthrough Therapy Designation BTD in the US for the treatment of patients with metastatic nonsmall cell lung cancer NSCLC whose tumors have a HER mutation and with disease pr...